Related Experiment Video
Updated: Aug 8, 2026
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta
1Department of Microbiology, University of Alabama at Birmingham 35294, USA.
Insights
Interleukin-1 beta and interferon-gamma differentially regulate complement component 3 (C3) expression in human astroglioma cells. Both cytokines influence C3 at the transcriptional level, crucial for understanding CNS inflammation.
Area of Science:
- Neuroimmunology
- Complement System Biology
- Cytokine Signaling
Background:
- Astrocytes play a key role in central nervous system (CNS) inflammation.
- The complement system, particularly C3, is implicated in neuroinflammatory and autoimmune diseases.
- Cytokines like IFN-gamma and IL-1 beta are critical mediators in immune responses within the CNS.
Purpose of the Study:
- To investigate the regulation of complement component 3 (C3) gene expression by interferon-gamma (IFN-gamma) and interleukin-1 beta (IL-1 beta) in a human astroglioma cell line.
- To elucidate the mechanisms by which these cytokines modulate C3 expression at the protein and transcriptional levels.
Main Methods:
- Treatment of human astroglioma cells with IFN-gamma and IL-1 beta.
- Assessment of C3 protein expression levels.
- Evaluation of the role of de novo protein synthesis using cycloheximide.
- Analysis of transcriptional regulation using Actinomycin D to inhibit gene induction.
Main Results:
- IL-1 beta induced C3 protein expression significantly faster (ten-fold) than IFN-gamma.
- IFN-gamma-stimulated C3 expression required de novo protein synthesis.
- Cycloheximide and IL-1 beta treatment markedly increased C3 expression.
- Actinomycin D inhibited C3 gene induction by both IFN-gamma and IL-1 beta, indicating transcriptional regulation.
Conclusions:
- Both IFN-gamma and IL-1 beta enhance C3 expression in astrocytes, partly through transcriptional mechanisms.
- Differential kinetics and regulatory pathways exist for IL-1 beta and IFN-gamma in modulating C3 expression.
- Understanding astrocyte complement gene regulation by cytokines is vital for studying CNS inflammation and autoimmune disorders.
Abstract:
In this report, we examined interferon-gamma (IFN-gamma) and interleukin-1 beta (IL-1 beta)-mediated regulation of the expression of C3, the third component of complement, in a human astroglioma cell line. Interleukin-1 beta induced C3 protein expression ten-fold more rapidly than IFN-gamma. De novo protein synthesis was required for IFN-gamma to stimulate C3 expression, while cycloheximide and IL-1 beta treatment of cells markedly increased C3 expression. Actinomycin D, inhibited C3 gene induction by IFN-gamma and IL-1 beta suggesting that these cytokines act, in part, at the transcriptional level to enhance C3 expression. Understanding cytokine-mediated regulation of complement gene expression in the astrocyte is important in defining the role of these molecules in CNS inflammation and autoimmune diseases.
